Research Archive — Page 8 of 134
-
January 14, 2026
Research reveals B cells’ more sinister role in progression of Type 1 diabetes
B cells are immune cells thought to drive the immune system’s attack on insulin-producing beta cells by activating anti-islet T cells. -
January 12, 2026
Guide published for outpatient cancer treatment with bispecific antibodies
Vanderbilt-Ingram was among the first in the nation to establish outpatient protocols for another personalized immunotherapy, CAR-T. -
January 9, 2026
Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study
The retrospective study analyzed the electronic health records of 1,257 patients ages 18 to 65 who underwent bariatric surgery at Vanderbilt Health from 2017 to 2022, and 1,809 patients treated with the drugs semaglutide or tirzepatide from 2018 to 2023. -
January 8, 2026
Patients with clonal hematopoiesis have increased heart disease risk following cancer treatment
Study supports the potential benefits of screening patients for CHIP before they undergo cancer treatment so they can be more closely monitored for heart complications. -
January 7, 2026
Study identifies potential target for blood cancer treatment, prevention
The findings could lead to new treatments for blood cancers, which kill an estimated 23,540 people in the United States every year. -
January 5, 2026
AI gets risk wrong in the clinic
Large language models have become far better than you at solving math problems but may still be bad at employing probabilistic terms in medical contexts. -
December 15, 2025
Antibody research may lead to broadly protective flu vaccine
These findings could lead to the development of cross-reactive and neutralizing antibody therapies for individuals who are severely ill from the flu.